Activated coagulation times in normal cats and dogs using MAX-ACT tubes

Veterinary clinicians frequently require rapid assessments of blood clotting function to manage critically ill patients. Standardized reference intervals for bedside coagulation monitoring remain limited for common companion animals. No prior work had resolved the specific performance characteristics of the MAX-ACT system in feline and canine populations. This gap motivated the current investigation into establishing reliable baseline data. Existing diagnostic protocols often rely on laboratory-based assays that require significant time and specialized equipment. Practitioners need accessible tools to differentiate normal physiological responses from pathological coagulopathies. That uncertainty drove the need for a validated, point-of-care technique suitable for routine clinical practice. Establishing these benchmarks provides a foundation for interpreting abnormal clotting times in diverse veterinary settings.

The aim of this research is to define standard reference intervals for clotting function in healthy cats and dogs. Clinicians currently lack validated benchmarks for interpreting results obtained from these specific testing tubes. This uncertainty drove the need to quantify normal physiological ranges for both feline and canine species. The researchers sought to determine whether the device provides consistent data across different animal populations. By excluding subjects with pre-existing hematological conditions, the team ensured the accuracy of the baseline values. This gap motivated the development of a clear diagnostic threshold for identifying abnormal clotting profiles. The study also investigates the impact of minor variations in blood collection techniques on the final measurements. Providing these reference values enables practitioners to make more informed decisions during routine patient assessments.

Review approach involved recruiting 43 feline and 50 canine subjects for prospective evaluation. The team excluded individuals presenting with clinical signs of anemia or abnormal baseline clotting profiles. Investigators performed venipuncture to obtain blood for both the primary assay and supplementary hematological screening. They maintained samples at a consistent thermal environment of 37 degrees Celsius throughout the procedure. Staff mixed the blood gently within the specialized tubes for a duration of 30 seconds. The protocol required monitoring for magnet immobilization every five to ten seconds by tilting the vessel. Researchers validated the precision of the method by running simultaneous duplicate samples from single needle insertions. This systematic design ensured that the resulting reference intervals accurately reflected healthy physiological states.

Key findings from the literature indicate that healthy cats exhibit a mean clotting time of 66 seconds, with a range between 55 and 85 seconds. Canine subjects demonstrated a slightly higher mean value of 71 seconds, spanning from 55 to 80 seconds. The analysis revealed no significant difference between duplicate samples collected from the same venipuncture site. These results confirm the reproducibility of the testing system in a clinical setting. The researchers successfully established clear thresholds for identifying potential coagulation disorders in both species. Data from the study suggest that any measurement surpassing 85 seconds represents an abnormal finding. This specific cutoff point serves as a trigger for further diagnostic investigation in veterinary patients. The consistency of these values provides a reliable benchmark for future clinical applications.

The researchers propose that a MAX-ACT duration exceeding 85 seconds warrants clinical concern in both species. Synthesis and implications suggest that values above this threshold necessitate comprehensive secondary coagulation screening. The authors observe that the provided reference ranges offer a practical guide for bedside diagnostic decision-making. Their data indicate that the testing system performs consistently across healthy feline and canine subjects. The team notes that the technique remains stable even when blood collection procedures vary slightly. These findings support the utility of the device for rapid assessment of patient hemostasis. The study highlights the importance of integrating these results with broader clinical evaluations. Practitioners should interpret these measurements alongside other hematological parameters to ensure diagnostic accuracy.